母胎界面IL-33对蜕膜免疫细胞功能的影响及机制
The Effect and Mechanism of IL-33 on Decidual Immune Cell Function at Maternal-Fetal Interface
DOI: 10.12677/acm.2025.1541094, PDF,   
作者: 王浩然, 王宝茜:山东大学第二医院检验医学中心,山东 济南
关键词: 母胎界面IL-33蜕膜免疫细胞Maternal-Fetal Interface IL-33 Decidual Immune Cells
摘要: 白细胞介素-33 (IL-33)是一种与多种免疫调节过程相关的细胞因子,它在免疫调节、炎症反应以及多种疾病的发生发展过程中发挥着重要作用,亦在维持妊娠状态下的免疫稳态中扮演重要角色。母胎界面由滋养细胞、蜕膜基质细胞及蜕膜免疫细胞构成,其中蜕膜免疫细胞包括自然杀伤(NK)细胞、T细胞、B细胞、巨噬细胞、树突状细胞等。妊娠过程中,胎儿对于母体而言为同种半异体移植物,因此保持母胎界面的免疫平衡尤为重要,而本文通过研究IL-33对于蜕膜免疫细胞的影响及相关机制的研究进展,从而进一步探索了妊娠过程中母胎局部免疫平衡的维持。
Abstract: Interleukin-33 (IL-33) is a cytokine involved in a variety of immunomodulatory processes, which plays an important role in immune regulation, inflammation and the occurrence and development of various diseases, and also plays an important role in the maintenance of immune homeostasis during pregnancy. The maternal-fetal interface is composed of trophoblast cells, decidual stromal cells and decidual immune cells, among which decidual immune cells include natural killer (NK) cells, T cells, B cells, macrophages and dendritic cells. During pregnancy, the fetus is an allogeneic and semi-allogeneic graft from the mother, so it is particularly important to maintain the immune balance at the mother-fetus interface. In this paper, the influence of IL-33 on decidual immune cells and the related mechanisms have been studied, so as to further explore the maintenance of the local immune balance in the mother and fetus during pregnancy.
文章引用:王浩然, 王宝茜. 母胎界面IL-33对蜕膜免疫细胞功能的影响及机制[J]. 临床医学进展, 2025, 15(4): 1577-1585. https://doi.org/10.12677/acm.2025.1541094

参考文献

[1] Afferni, C., Buccione, C., Andreone, S., Galdiero, M.R., Varricchi, G., Marone, G., et al. (2018) The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity. Frontiers in Immunology, 9, Article 2601. [Google Scholar] [CrossRef] [PubMed]
[2] Martin, N.T. and Martin, M.U. (2016) Interleukin 33 Is a Guardian of Barriers and a Local Alarmin. Nature Immunology, 17, 122-131. [Google Scholar] [CrossRef] [PubMed]
[3] Miller, J.E., Koti, M. and Tayade, C. (2022) IL-33-ILC2 Axis in the Female Reproductive Tract. Trends in Molecular Medicine, 28, 569-582. [Google Scholar] [CrossRef] [PubMed]
[4] Huang, J., Gandini, M.A., Chen, L., M’Dahoma, S., Stemkowski, P.L., Chung, H., et al. (2020) Hyperactivity of Innate Immunity Triggers Pain via TLR2-Il-33-Mediated Neuroimmune Crosstalk. Cell Reports, 33, Article 108233. [Google Scholar] [CrossRef] [PubMed]
[5] 闫雪, 刘晶瑶, 刘红超, 等. IL-33在中枢神经系统疾病中的调控作用[J]. 中国实验诊断学, 2020, 24(9): 1567-1570.
[6] Valero-Pacheco, N., Tang, E.K., Massri, N., Loia, R., Chemerinski, A., Wu, T., et al. (2022) Maternal IL-33 Critically Regulates Tissue Remodeling and Type 2 Immune Responses in the Uterus during Early Pregnancy in Mice. Proceedings of the National Academy of Sciences, 119, e2123267119. [Google Scholar] [CrossRef] [PubMed]
[7] Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T.K., et al. (2005) IL-33, an Interleukin-1-Like Cytokine That Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity, 23, 479-490. [Google Scholar] [CrossRef] [PubMed]
[8] Hardman, C. and Ogg, G. (2016) Interleukin-33, Friend and Foe in Type-2 Immune Responses. Current Opinion in Immunology, 42, 16-24. [Google Scholar] [CrossRef] [PubMed]
[9] Tago, K., Noda, T., Hayakawa, M., Iwahana, H., Yanagisawa, K., Yashiro, T., et al. (2001) Tissue Distribution and Subcellular Localization of a Variant Form of the Human ST2 Gene Product, ST2V. Biochemical and Biophysical Research Communications, 285, 1377-1383. [Google Scholar] [CrossRef] [PubMed]
[10] Molofsky, A.B., Savage, A.K. and Locksley, R.M. (2015) Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity, 42, 1005-1019. [Google Scholar] [CrossRef] [PubMed]
[11] Cayrol, C. and Girard, J. (2018) Interleukin‐33 (Il‐33): A Nuclear Cytokine from the Il‐1 Family. Immunological Reviews, 281, 154-168. [Google Scholar] [CrossRef] [PubMed]
[12] Yuan, C. (2022) IL-33 in Autoimmunity; Possible Therapeutic Target. International Immunopharmacology, 108, Article 108887. [Google Scholar] [CrossRef] [PubMed]
[13] Carriere, V., Roussel, L., Ortega, N., Lacorre, D., Americh, L., Aguilar, L., et al. (2007) IL-33, the Il-1-Like Cytokine Ligand for ST2 Receptor, Is a Chromatin-Associated Nuclear Factorin Vivo. Proceedings of the National Academy of Sciences, 104, 282-287. [Google Scholar] [CrossRef] [PubMed]
[14] Roussel, L., Erard, M., Cayrol, C. and Girard, J. (2008) Molecular Mimicry between IL‐33 and KSHV for Attachment to Chromatin through the H2A-H2B Acidic Pocket. EMBO reports, 9, 1006-1012. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, F., Tossberg, J.T., Spurlock, C.F., Yao, S., Aune, T.M. and Sriram, S. (2014) Expression of Il‐33 and Its Epigenetic Regulation in Multiple Sclerosis. Annals of Clinical and Translational Neurology, 1, 307-318. [Google Scholar] [CrossRef] [PubMed]
[16] Augustine, J., Pavlou, S., Ali, I., Harkin, K., Ozaki, E., Campbell, M., et al. (2019) IL-33 Deficiency Causes Persistent Inflammation and Severe Neurodegeneration in Retinal Detachment. Journal of Neuroinflammation, 16, Article No. 251. [Google Scholar] [CrossRef] [PubMed]
[17] Liew, F.Y., Girard, J. and Turnquist, H.R. (2016) Interleukin-33 in Health and Disease. Nature Reviews Immunology, 16, 676-689. [Google Scholar] [CrossRef] [PubMed]
[18] Endo, Y., Hirahara, K., Iinuma, T., Shinoda, K., Tumes, D.J., Asou, H.K., et al. (2015) The Interleukin-33-P38 Kinase Axis Confers Memory T Helper 2 Cell Pathogenicity in the Airway. Immunity, 42, 294-308. [Google Scholar] [CrossRef] [PubMed]
[19] Taniguchi, S., Elhance, A., Van Duzer, A., Kumar, S., Leitenberger, J.J. and Oshimori, N. (2020) Tumor-Initiating Cells Establish an Il-33-TGF-β Niche Signaling Loop to Promote Cancer Progression. Science, 369, eaay1813. [Google Scholar] [CrossRef] [PubMed]
[20] Gordon, E.D., Simpson, L.J., Rios, C.L., Ringel, L., Lachowicz-Scroggins, M.E., Peters, M.C., et al. (2016) Alternative Splicing of Interleukin-33 and Type 2 Inflammation in Asthma. Proceedings of the National Academy of Sciences, 113, 8765-8770. [Google Scholar] [CrossRef] [PubMed]
[21] Cayrol, C. and Girard, J. (2014) IL-33: An Alarmin Cytokine with Crucial Roles in Innate Immunity, Inflammation and Allergy. Current Opinion in Immunology, 31, 31-37. [Google Scholar] [CrossRef] [PubMed]
[22] Jabrane-Ferrat, N. (2019) Features of Human Decidual NK Cells in Healthy Pregnancy and during Viral Infection. Frontiers in Immunology, 10, Article 1397. [Google Scholar] [CrossRef] [PubMed]
[23] Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., et al. (2001) Human Natural Killer Cells: A Unique Innate Immunoregulatory Role for the CD56bright Subset. Blood, 97, 3146-3151. [Google Scholar] [CrossRef] [PubMed]
[24] Seshadri, S. and Sunkara, S.K. (2014) Natural Killer Cells in Female Infertility and Recurrent Miscarriage: A Systematic Review and Meta-Analysis. Human Reproduction Update, 20, 429-438. [Google Scholar] [CrossRef] [PubMed]
[25] El‐Azzamy, H., Dambaeva, S.V., Katukurundage, D., Salazar Garcia, M.D., Skariah, A., Hussein, Y., et al. (2018) Dysregulated Uterine Natural Killer Cells and Vascular Remodeling in Women with Recurrent Pregnancy Losses. American Journal of Reproductive Immunology, 80, e13024. [Google Scholar] [CrossRef] [PubMed]
[26] Hu, W., Huang, L., Li, M., Jin, L., Li, D. and Zhu, X. (2015) Decidual Stromal Cell-Derived IL-33 Contributes to Th2 Bias and Inhibits Decidual NK Cell Cytotoxicity through NF-κB Signaling in Human Early Pregnancy. Journal of Reproductive Immunology, 109, 52-65. [Google Scholar] [CrossRef] [PubMed]
[27] Faas, M., Ipseiz, N., Ackermann, J., Culemann, S., Grüneboom, A., Schröder, F., et al. (2021) Il-33-Induced Metabolic Reprogramming Controls the Differentiation of Alternatively Activated Macrophages and the Resolution of Inflammation. Immunity, 54, 2531-2546.e5. [Google Scholar] [CrossRef] [PubMed]
[28] Sheng, Y., Hu, W., Shen, H., Wei, C., Liu, Y., Ma, X., et al. (2022) An Imbalance of the Il-33/ST2-AXL-Efferocytosis Axis Induces Pregnancy Loss through Metabolic Reprogramming of Decidual Macrophages. Cellular and Molecular Life Sciences, 79, Article No. 173. [Google Scholar] [CrossRef] [PubMed]
[29] Sheng, Y., Hu, W., Wei, C., Tang, L., Liu, Y., Liu, Y., et al. (2018) Il‐33/ST2 Axis Affects the Polarization and Efferocytosis of Decidual Macrophages in Early Pregnancy. American Journal of Reproductive Immunology, 79, e12836. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, W., Sung, N., Gilman-Sachs, A. and Kwak-Kim, J. (2020) T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Frontiers in Immunology, 11, Article 2025. [Google Scholar] [CrossRef] [PubMed]
[31] Wang, M., Zhong, J. and Xiang, Y. (2021) LncRNA‐GAS5 Related to the Processes of Recurrent Pregnancy Loss by Regulating Th1/Th2 Balance. The Kaohsiung Journal of Medical Sciences, 37, 479-486. [Google Scholar] [CrossRef] [PubMed]
[32] Luo, J., Wang, Y., Qi, Q., Cheng, Y., Xu, W. and Yang, J. (2021) Sinomenine Improves Embryo Survival by Regulating Th1/Th2 Balance in a Mouse Model of Recurrent Spontaneous Abortion. Medical Science Monitor, 27, e927709. [Google Scholar] [CrossRef] [PubMed]
[33] Lan, Y., Li, Y., Yang, X., Lei, L., Liang, Y. and Wang, S. (2021) Progesterone-Induced Blocking Factor-Mediated Th1/Th2 Balance Correlates with Fetal Arrest in Women Who Underwent in Vitro Fertilization and Embryo Transfer. Clinical Immunology, 232, Article 108858. [Google Scholar] [CrossRef] [PubMed]
[34] Bahrami-Asl, Z., Farzadi, L., Fattahi, A., Yousefi, M., Quinonero, A., Hakimi, P., et al. (2020) Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF). Geburtshilfe und Frauenheilkunde, 80, 851-862. [Google Scholar] [CrossRef] [PubMed]
[35] Arefieva, A., Nikolaeva, M., Stepanova, E., Krechetova, L., Golubeva, E., Tetruashvili, N., et al. (2021) Association of CD200 Expression in Paternal Lymphocytes with Female Th1/Th2 Balance and Pregnancy Establishment at Immunotherapy of Recurrent Spontaneous Abortion. American Journal of Reproductive Immunology, 85, e13355. [Google Scholar] [CrossRef] [PubMed]
[36] Komai-Koma, M., Wang, E., Kurowska-Stolarska, M., Li, D., McSharry, C. and Xu, D. (2016) Interleukin-33 Promoting Th1 Lymphocyte Differentiation Dependents on Il-12. Immunobiology, 221, 412-417. [Google Scholar] [CrossRef] [PubMed]
[37] Lu, H., Huang, Y., Xin, H., Hao, C. and Cui, Y. (2018) The Expression of Cytokines IFN-γ, IL-4, IL-17A, and TGF-β1 in Peripheral Blood and Follicular Fluid of Patients Testing Positive for Anti-Thyroid Autoantibodies and Its Influence on in Vitro Fertilization and Embryo Transfer Pregnancy Outcomes. Gynecological Endocrinology, 34, 933-939. [Google Scholar] [CrossRef] [PubMed]
[38] Peine, M., Marek, R.M. and Löhning, M. (2016) IL-33 in T Cell Differentiation, Function, and Immune Homeostasis. Trends in Immunology, 37, 321-333. [Google Scholar] [CrossRef] [PubMed]
[39] Matta, B.M., Lott, J.M., Mathews, L.R., Liu, Q., Rosborough, B.R., Blazar, B.R., et al. (2014) IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells to Selectively Expand IL-33R/ST2+ Regulatory T Cells. The Journal of Immunology, 193, 4010-4020. [Google Scholar] [CrossRef] [PubMed]
[40] Bartmann, C., Segerer, S.E., Rieger, L., Kapp, M., Sütterlin, M. and Kämmerer, U. (2014) Quantification of the Predominant Immune Cell Populations in Decidua Throughout Human Pregnancy. American Journal of Reproductive Immunology, 71, 109-119. [Google Scholar] [CrossRef] [PubMed]
[41] 阴月, 王丽雪, 董宁, 等. 白细胞介素-33对脓毒症小鼠脾脏树突状细胞免疫功能的影响[J]. 感染、炎症、修复, 2019, 20(4): 247-252.
[42] Blois, S.M., Joachim, R., Kandil, J., Margni, R., Tometten, M., Klapp, B.F., et al. (2004) Depletion of CD8+ Cells Abolishes the Pregnancy Protective Effect of Progesterone Substitution with Dydrogesterone in Mice by Altering the Th1/Th2 Cytokine Profile. The Journal of Immunology, 172, 5893-5899. [Google Scholar] [CrossRef] [PubMed]
[43] Leng, Y., Romero, R., Xu, Y., Galaz, J., Slutsky, R., Arenas‐Hernandez, M., et al. (2019) Are B Cells Altered in the Decidua of Women with Preterm or Term Labor? American Journal of Reproductive Immunology, 81, e13102. [Google Scholar] [CrossRef] [PubMed]
[44] Dutta, S., Sengupta, P. and Haque, N. (2020) Reproductive Immunomodulatory Functions of B Cells in Pregnancy. International Reviews of Immunology, 39, 53-66. [Google Scholar] [CrossRef] [PubMed]
[45] Zhu, J., Xu, Y., Zhao, J., Li, X., Meng, X., Wang, T., et al. (2018) IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response. Journal of Immunology Research, 2018, Article ID: 1827901. [Google Scholar] [CrossRef] [PubMed]
[46] Mi, Z., Zhao, L., Sun, M., Gao, T., Wang, Y., Sui, B., et al. (2021) Overexpression of Interleukin-33 in Recombinant Rabies Virus Enhances Innate and Humoral Immune Responses through Activation of Dendritic Cell-Germinal Center Reactions. Vaccines, 10, Article 34. [Google Scholar] [CrossRef] [PubMed]
[47] Stier, M.T., Mitra, R., Nyhoff, L.E., Goleniewska, K., Zhang, J., Puccetti, M.V., et al. (2019) IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development. The Journal of Immunology, 203, 1457-1467. [Google Scholar] [CrossRef] [PubMed]
[48] Huang, B., Faucette, A.N., Pawlitz, M.D., Pei, B., Goyert, J.W., Zhou, J.Z., et al. (2017) Interleukin-33-Induced Expression of PIBF1 by Decidual B Cells Protects against Preterm Labor. Nature Medicine, 23, 128-135. [Google Scholar] [CrossRef] [PubMed]
[49] Valeff, N., Juriol, L., Quadrana, F., Muzzio, D.O., Zygmunt, M., Quiroga, M.F., et al. (2020) Expression of IL-33 Receptor Is Significantly Up-Regulated in B Cells during Pregnancy and in the Acute Phase of Preterm Birth in Mice. Frontiers in Immunology, 11, Article 446. [Google Scholar] [CrossRef] [PubMed]
[50] Kraus, T.A., Engel, S.M., Sperling, R.S., Kellerman, L., Lo, Y., Wallenstein, S., et al. (2012) Characterizing the Pregnancy Immune Phenotype: Results of the Viral Immunity and Pregnancy (VIP) Study. Journal of Clinical Immunology, 32, 300-311. [Google Scholar] [CrossRef] [PubMed]
[51] Zhang, L., Chang, K.K., Li, M.Q., et al. (2014) Mouse Endometrial Stromal Cells and Progesterone Inhibit the Activation and Regulate the Differentiation and Antibody Secretion of Mouse B Cells. International Journal of Clinical and Experimental Pathology, 7, 123-133.